TGA approves first oral T2DM treatment for kids since metformin
Dr Gary Deed says empagliflozin is a ‘wonderful addition’ to the therapeutic options.
The TGA has approved empagliflozin for type 2 diabetes in children as young as 10, either combined with metformin or as monotherapy if metformin is not tolerated.
The updated product information flags a starting dose of 10mg, which can be increased up to 25mg daily for patients needing further glycaemic control.
